Technical Analysis for MYO - Myomo Inc.

Grade Last Price % Change Price Change
grade F 1.85 -0.54% -0.01
MYO closed down 0.54 percent on Friday, October 19, 2018, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Earnings due: Nov 5

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical MYO trend table...

Date Alert Name Type % Chg
Oct 19 Narrow Range Bar Range Contraction 0.00%
Oct 19 Oversold Stochastic Weakness 0.00%
Oct 18 Narrow Range Bar Range Contraction -0.54%
Oct 18 NR7 Range Contraction -0.54%
Oct 18 NR7-2 Range Contraction -0.54%
Oct 18 Oversold Stochastic Weakness -0.54%
Oct 17 Narrow Range Bar Range Contraction -1.07%
Oct 17 NR7 Range Contraction -1.07%
Oct 17 Inside Day Range Contraction -1.07%
Oct 17 Oversold Stochastic Weakness -1.07%

Older signals for MYO ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Myomo, Inc. is a commercial stage medical robotics Company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis. Based on patented technology developed at MIT and the Company, Myomo develops and markets the MyoPro® product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed or weakened arms and hands of individuals that have suffered a stroke, spinal cord or nerve injury such as brachial plexus injury, or other neuromuscular disability such as amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS). It is provided through clinical relationships with VA medical centers, leading rehabilitation hospitals, and Orthotics and Prosthetics (“O&P”) practices. Several hundred have been successfully used by patients. It is the only device that, sensing a patient’s own neurological signals through non-invasive sensors on the arm, can restore their ability to use their arms and hands so that they can return to work, live independently and reduce their cost of care. Myomo is headquartered in Cambridge, Massachusetts, with sales and clinical professionals across the U.S. For more information, please visit www.myomo.com.
Is MYO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 11.4
52 Week Low 1.74
Average Volume 98,950
200-Day Moving Average 3.0802
50-Day Moving Average 1.9964
20-Day Moving Average 1.9425
10-Day Moving Average 1.878
Average True Range 0.1138
ADX 15.37
+DI 17.708
-DI 13.8399
Chandelier Exit (Long, 3 ATRs ) 1.9486
Chandelier Exit (Short, 3 ATRs ) 2.1714
Upper Bollinger Band 2.0912
Lower Bollinger Band 1.7938
Percent B (%b) 0.19
BandWidth 15.310167
MACD Line -0.0594
MACD Signal Line -0.053
MACD Histogram -0.0064
Fundamentals Value
Market Cap 11.26 Million
Num Shares 6.09 Million
EPS -8.54
Price-to-Earnings (P/E) Ratio -0.22
Price-to-Sales 14.12
Price-to-Book 4.12
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.93
Resistance 3 (R3) 1.93 1.92 1.91
Resistance 2 (R2) 1.92 1.90 1.91 1.91
Resistance 1 (R1) 1.88 1.89 1.88 1.88 1.90
Pivot Point 1.87 1.87 1.86 1.86 1.87
Support 1 (S1) 1.83 1.85 1.83 1.83 1.80
Support 2 (S2) 1.82 1.84 1.81 1.79
Support 3 (S3) 1.78 1.82 1.79
Support 4 (S4) 1.78